The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...

Researchers have unveiled a breakthrough showing that a subset of colorectal tumors can be eliminated using immunotherapy alone, without chemotherapy or surgery. The finding signals a potential shift ...

Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial Participants received a ...

“Does colorectal cancer surgery mean the anus can’t be preserved?” ... A specialist answers ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1 ...

A pattern-based p53 immunohistochemistry test identified patients with colorectal liver metastases at nearly four times the ...

Neoadjuvant chemotherapy did not improve disease-free survival compared with upfront surgery in patients with locally advanced colon cancer in a randomized trial. However, neoadjuvant chemotherapy did ...

A new study in Cancer Discovery shows that circulating tumor DNA and immune cells drawn from a simple blood sample can ...

Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...